PAB
Click for more information
0.00% 0.7¢ patrys limited

Ann: PAT-DX1 Clinical Target Indications Confirmed, page-153

  1. redant
    3,131 Posts.
    lightbulb Created with Sketch. 244
    clock Created with Sketch.
    25/10/18
    10:24
    Post #: 36254263
    "• PAT-DX1 shows efficacy in animal model of triple negative breast cancer"
    A bit of information on TNBC -
    https://finance.yahoo.com/news/oncosec-initiates-keynote-890-phase-113000246.html
    PAB Price at posting: 3.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Real estate dynamics & changes raise investor doubt
right-arrow Created with Sketch.
PEC Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil
right-arrow Created with Sketch.
FMG Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%
right-arrow Created with Sketch.
MM1 Geochemical work at Newington picks up gold and copper anomalies for Midas
right-arrow Created with Sketch.
MCT Metalicity looking for offers on Admiral Bay zinc project
right-arrow Created with Sketch.
FG1 Flynn Gold flags mid-grade drill hits and always eye-catching rock chips
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.7¢ 		Change
0.000(0.00%) 		Mkt cap ! $14.40M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $1.4K 200K

Buyers (Bids)

No. Vol. Price($)
2 1074999 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
0.8¢ 1379932 3
View Market Depth
Last trade - 10.06am 25/07/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.